Increasing the Potency of T Cell Cancer Therapy

GEN News Highlights, 21 November 2017,

In the United Kingdom, Cardiff University researchers have used CRISPR to create T cells up to a thousand times more sensitive to cancer cells.  These cells have been edited to remove their own T-cell receptors, leaving only those targeting cancer cells.  The hope is that custom immunotherapies such as this may one day replace conventional cancer therapies.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply